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Deep sequencing of cDNAsmade from splicedmRNAs indicates that most coding genes
in many animals and plants have pre-mRNA transcripts that are alternatively spliced. In
pre-mRNAs, in addition to invariant exons that are present in almost all mature mRNA
products, there are at least 6 additional types of exons, such as exons from alternative
promoters or with alternative polyA sites, mutually exclusive exons, skipped exons, or
exons with alternative 5′ or 3′ splice sites. Our bioinformatics-based hypothesis is that,
in analogy to the genetic code, there is an “alternative-splicing code” in introns and
flanking exon sequences, analogous to the genetic code, that directs alternative splicing
of many of the 36 types of introns. In humans, we identified 42 different consensus
sequences that are each present in at least 100 human introns. 37 of the 42 top
consensus sequences are significantly enriched or depleted in at least one of the 36
types of introns. We further supported our hypothesis by showing that 96 out of 96
analyzed human disease mutations that affect RNA splicing, and change alternative
splicing from one class to another, can be partially explained by a mutation altering a
consensus sequence from one type of intron to that of another type of intron. Some of
the alternative splicing consensus sequences, and presumably their small-RNA or protein
targets, are evolutionarily conserved from 50 plant to animal species. We also noticed the
set of introns within a gene usually share the same splicing codes, thus arguing that one
sub-type of splicesosome might process all (or most) of the introns in a given gene. Our
work sheds new light on a possible mechanism for generating the tremendous diversity
in protein structure by alternative splicing of pre-mRNAs.
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INTRODUCTION
The almost invariant consensus sequence for mRNA splicing
in animals and plants is gu_ag, where gu is the splice donor
sequence and ag is the splice acceptor sequence. A longer splice
donor consensus sequence in most mammals is guragu, where r
is either g or a (Mount, 1982; Black, 2003). Usually, an expression
of “gu_ag” means that only the 5′ and 3′ terminal two nucleotides
of the sequence are invariable as gu and ag, respectively, and
that a sequence represented by the underscore can be any
sequences. However, here we use this expression to indicate that
the sequence represented by the underscore can be any sequences
except for sequences that do notmatch any of the other consensus
sequences.
The splice acceptor consensus sequence is preceded by a
branch point sequence, which contains an adenine, which is
ligated to the 5′ splice site ribonucleotide to form the intron
lariat, and a polypyrimidine tract (c or u), which is between
the branch point and the splice acceptor sequence. While the
short gu_ag consensus sequence of introns is clearly not sufficient
to differentiate amongst the multitude of alternative splicing
events, surprisingly little is known about what other sequence
information is required to regulate alternative RNA splicing
(Ladd and Cooper, 2002; Barash et al., 2010; Witten and Ule,
2011). The flanking one or two nucleotides on either side of
the intron are also often conserved, and they are included in
our supplementary tables, but they will not be discussed further
in this paper so that we can focus our analyses on consensus
sequences at the ends of the introns.
Alternative RNA splicing occurs in almost all human genes
and vastly increases the number of proteins and transcripts
that an organism can produce (Pan et al., 2008; Wang et al.,
2008). Exons that are involved in all types of RNA splicing can
be classified into five major categories: (1) exons containing
alternative 5′ splice sites (A5), (2) exons containing alternative 3′
splice sites (A3), (3) retained or invariant exons (R), (4) skipped
exons (S), and (5) mutually exclusive exons (ME) (Ast, 2004;
Sugnet et al., 2004). In addition to these five types of exons, we
also include in our bioinformatics analysis exons that contain an
alternative promoter (APr) and exons that contain an alternative
poly A (APA) site to make a total of 7 exon types. Since an intron
is flanked by two exons, APr can only be at the 5′ end, and APA
can only be at the 3′ end, there are 36 possible pair-wise types
of introns that are distinguished by the combinations of 7 types
of flanking exons. Here we present bioinformatics evidence to
support our hypothesis that there is an alternative splicing code
based on the 36 different types of introns.
RESULTS
We hypothesize that there are 36 different types of introns with
unique consensus sequences based on their flanking exon types.
To test this hypothesis, we analyzed the 36 different types of
introns separately rather than combining all introns into one
pool, as is usually done in bioinformatics studies of introns (e.g.,
Mount, 1982). It is possible, for instance, that there are many
different types of macromolecular splicesosome complexes, in
addition to the canonical U2-type splicesosomes and the non-
canonical U12-type splicesosomes (Padgett, 2012), that utilize
the numerous U2-variant small RNA sequences in the genome
(O’Reilly et al., 2013). To test this hypothesis, we determined
whether the 36 types of introns are enriched for a particular
paired consensus sequence(s) that is derived from both ends of
the intron and flanking exon regions. Supplementary Table 1 has
a list of all 36 types of introns and the number of introns in each
class in H. sapiens, M. musculis, D. melanogaster, C. elegans, and
A. thaliana.
To begin our bioinformatics analysis of introns, we first
generated a table of paired splice donor and acceptor consensus
sequences, from the most common to the least common (see
Materials and Methods). For statistical reasons, we selected
an arbitrary cutoff of each paired consensus sequence being
represented by at least 100 introns. Using a modification of our
program SnpEff, which classifies sequences in any sequenced
genome (Cingolani et al., 2012), we analyzed the genomes and
compared them with annotated full-length RefSeq cDNAs of 50
different plant and animal species. The total number of different
types of paired consensus sequences ranged from one in baker’s
yeast, Saccharomyces cerevisiae, guaugu_ag, which has only 282
introns, all of which are always flanked by invariant exons (R-R),
to 95 different consensus sequences in the marmoset, which has
184,882 introns (Supplementary Table 2). The average number
of introns in the 50 species that we analyzed was 116,288 with
a standard deviation of 45,266. Almost half of the animals’
genomes that we analyzed have between 40 and 50 different
types of paired consensus sequences with at least 100 introns in
each type. Table 1 shows the 42 consensus sequences in humans,
which are in at least 100 introns, in rank order from most
common to least common.
Second, the 42 different paired consensus sequences in
humans (Table 1) were analyzed individually to determine
whether they are enriched or depleted for any of 36 types of
introns (see Materials and Methods). The 36 types of introns are
written in the form Xa–Xb, where X is one of the seven types of
exon, and the Xa exon precedes the Xb exon in the same gene.
For example, the class A5-A3 is an intron that is flanked by an
upstream exon with an alternative 5′ splice site and a downstream
exon with an alternative 3′ splice site. In Figure 1A, all 4 types of
splicing, indicated with dashed lines, would generate introns in
the A5-A3 class. Figures 1B–D show R-R, S-S, and A3-S classes
of introns and the consensus sequences that aremost significantly
enriched for these classes of introns. Notice that there are only
36 possibly combinations for the 7 types of exons rather than 49
(i.e., 72 = 49) because alternative poly A (APA) is never first (Xa)
and alternative promoter (APr) is never second (Xb) in the Xa-Xb
nomenclature system.
In an attempt to concisely summarize our analyses, Table 2
shows an “alternative splicing code” for human introns in a
format similar to the genetic code. The left column indicates the
exon type upstream on the intron (APr, 3S, 5S, ME, R, and S) and
the top row indicates the exon type downstream of the intron (3S,
5S, ME, R, S, and APA). The numbers in the table show the intron
consensus sequences that are most significantly enriched (upper
cell) and depleted (lower cell) for the indicated class of intron.
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TABLE 1 | The top 42 ranked intron consensus sequences in humans.
Rank 5S-3S Count
0 ALL 215,155
1 gugagu_ag 30,585
2 guaag_ag 29,538
3 guaagu_ag 28,972
4 gugag_ag 26,627
5 guaa_ag 22,188
6 gua_ag 20,040
7 guagg_ag 12,474
8 guaugu_ag 6,312
9 guaug_ag 5,552
10 guggg_cag 5,168
11 gu_ag 4,901
12 guga_ag 3,332
13 gucagu_ag 2,439
14 gugcg_cag 1,904
15 gucag_ag 1,650
16 gugugu_ag 1,421
17 guuagu_ag 1,415
18 guuugu_ag 1,113
19 gcaagu_ag 967
20 guuggu_ag 929
21 gugggu_ag 918
22 gugug_ag 912
23 guggg_ag 719
24 gucugu_ag 450
25 gucug_ag 371
26 gugcgu_ag 311
27 gcaag_ag 301
28 gugcg_ag 255
29 guauccuuu_ag 250
30 gc_ag 230
31 gucgg_cag 202
32 guca_ag 198
33 guccg_ag 162
34 gcagg_ag 153
35 guucgu_ag 147
36 guauccuu_ag 144
37 auauccuu_ac 124
38 gua_ugguuucag 118
39 guaag_uguucag 117
40 gu_ugguuuuag 113
41 gcaug_ag 112
42 gu_uuugagacag 109
1–42 213,943 (99.44%)
Rank, the most to the least common consensus sequence. Donor-Acceptor (5S-3S), the
intron sequences of the donor and acceptor sequences. Count, the count number of
introns that have the indicated consensus sequence (N > 100). 1–42, the total number of
introns in rank 1–42 is 213,949, which represents 99.44% of the total number of introns
in humans.
Supplementary Figure 1 shows splicing diagrams of the 18 classes
of introns that have consensus motifs that are over-represented
for that intron class, and Supplementary Figure 2 shows splicing
diagrams of the 16 classes of introns that have consensus motifs
that are under-represented for that intron class. Notice that many
of the classes of introns have more than one over-represented
motif and more than one under-represented motif (Table 2),
indicating that the alternative splicing code, much like the genetic
code, is degenerate. Also, notice that almost half of the intron
types are not associated with consensus sequences, such as A3–
A5, possibly because macromolecular complexes presumably do
not exist that recognize certain rare types of alternative RNA
splicing event in humans.
Six of the 36 types of introns are enriched in the non-
canonical core consensus sequence gc_ag, including APr-
A3 (gc_ag, gcaag_ag, and gcaagu_ag), APr-R (gc_ag), A5-A3
(gc_ag and gcagg_ag), A5-R (gc_ag, gcaag_ag, gcaagu_ag, and
gcagg_ag), A5-S (gcaug_ag), and S-R (gcaug_ag) (Table 2).
However, the only intron type that is depleted in a non-canonical
core consensus sequence is R-R, which is depleted for gc_ag,
gcaag_ag, gcaagu_ag, and gcagg_ag (Table 2). We interpret this
as indicating that many types of alternative splicing events
utilize the non-canonical core consensus sequence gc_ag, but
that invariant splicing almost always uses the canonical core
consensus sequence gu_ag. These findings are consistent, with
slight variations indicated below, in all 50 species studied. A
complete list of paired consensus sequences is available upon
request, as well as enrichment (up) and depletion (down)
p-values for the 36 types of introns for each paired consensus
sequence, for all 50 organisms’ genomes that we analyzed (see
Supplementary Table 2 for a partial list).
In our analyses of the 50 species, the most frequent intron
class in most of the species is R-R, (e.g., 79% for H. sapiens, 29%
forM. musculis, 62% for D. melanogaster, 80% for C. elegans and
91% for A. thaliana) which means a invariant exon is followed by
another invariant exon (Figure 1B). The second most common
intron class, in most of the 50 species analyzed, is S-S (e.g., 5%
for H. sapiens, 22% for M. musculus, 4% for D. melanogaster,
and 3% for C. elegans), which means that two consecutive exons
are skipped, either together or individually, in mature RNA
(Figure 1C). Other studies, have suggested that exon skipping
is the most frequently occurring alternative splicing event. For
example, it was found that over one third of exons can be skipped
(∼38%) (Ast, 2004; Sugnet et al., 2004). “Pathological” exon
skipping is commonly seen in diseases with multiple disrupted
alternative splicing events, especially in cancer (Watson and
Watson, 2010).
There are many practical uses for understanding the
alternative RNA splicing code. For example, many diseases,
including cancer, have mutations that cause changes in
alternative RNA splicing that contribute to pathogenesis (Watson
and Watson, 2010). It is estimated that at least 15–50% of
mutations that cause human diseases affect splice-site selection
(Wang and Cooper, 2007; Singh and Cooper, 2012). Here we
show how the alternative RNA splicing code in Table 2 helps to
interpret human genetic diseases that are caused by mutations
near splice donor and acceptor sites that could not be adequately
explained without this code. Using the databases of disease-
causing mutations at spliced 3′ and 5′ splice sites, dbass5 and
dbass3 (http://www.dbass.org.uk/dbass5/viewlist.aspx; Singh and
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FIGURE 1 | Intron motifs that are over-represented in four representative alternative splicing classes. Left, diagram of alternative splicing classes A5-A3,
R-R, S-S, and A3-S. Middle, consensus sequence with most significant p-values for enrichment in this intron class (in parenthesis). Right, “logo plot” of consensus
sequences. The larger the letter, the more frequent the nucleotide. (A) A3–A5 (Alternative 5′ splice site followed by an alternative 3′ splice site). (B) R-R (Retained exon
followed by another retained exon). (C) S-S (Skipped exon followed by another skipped exon). (D) A3-S (Alternative 3′ splice site followed by a skipped exon).
TABLE 2 | The alternative mRNA splicing code for humans.
UP A3 A5 ME R S APA
APr 11, 19, 26–28, 30 None None 7, 10, 11, 14, 21, 22, 24, 30–33 7, 33, 42 None
2, 3, 8 3, 5, 8 5
A3 None None None 1, 4 2 None
5 3
A5 11, 14, 28, 30, 34, 42 4, 33 None 6, 10, 11, 14, 15, 19, 22, 25–28, 30–34 11, 12, 41, 42 None
2, 3, 5, 7, 8, 10 3 1–3, 9 1, 8
ME None None None None None None
1
R 1, 4, 32 None None 2–4, 8, 9, 29, 37 1, 3, 42 1, 7
5, 8, 11, 12, 17 7, 11, 16, 19, 21, 22, 24, 26, 27, 30–34, 42 11 4
S None 13 None 6, 11, 20, 22, 41 3, 5, 13, 17, 18 3
None 1, 4 4, 10, 14, 31 None
The rows indicate the first exon (exon i) and the columns indicate the second exon (exon i+1) that flank an intron with the indicated consensus sequences. Listed are the consensus
sequences that are significantly (P < 0.01) enriched (i.e., UP) for the indicated intron type (top numbers) and depleted for the indicated intron type (bottom numbers). The consensus
sequences are listed alphabetically. Notice that many intron types are not significantly positively and/or negatively associated with a consensus sequence (none). A3, alternative 3′ splice
site; A5, alternative 5′ splice site; ME, mutually exclusive exons; R, retained exons; S, skipped exons; APA, alternative polyA sites; APr, alternative promoter.
Cooper, 2012), we analyzed all intron mutations at intron
positions +3, +4, +5, and +6 (the first intron nucleotide at the
splice donor is +1) and successfully correlated the alternative
RNA splicing code to 96 different mutations in 56 genes
(Supplementary Table 3). For example, Menkes disease (MD),
which has several alleles in the ATP7A gene that are associated
with alternative splicing defects, is a lethal disorder of copper
metabolism that lead to severe neurological degeneration (Møller
et al., 2000). Occipital horn syndrome (OHS) is a milder allelic
form that is caused by partial loss of function of the ATP7A
gene (Møller et al., 2000). Both MD and OHS are caused by
mutations in the intronic sequences of the ATP7A gene, which
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encodes an ATPase that is responsible for copper eﬄux from cells
(Figure 2A; Nissim-Rafinia and Kerem, 2002).
In the ATP7A gene, two splice-site mutations (IVS6+1G>A,
IVS6+5G>A) for MD and one (IVS6+6T>A) for OHS were
identified in a previous study (Figure 2; Møller et al., 2000).
The main biological effect of the mutation in the first position
of the splice donor site of intron 6 (gu to au) is cryptic
downstream splice donor usage followed by exon 7 skipping
(Figure 2B; Møller et al., 2000). Exon skipping and cryptic splice
site activation are typical results of mutations in any of the four
core consensus bases, gu_ag, and can be explained without the
alternative splicing code. However, why the ATP7A mutation in
position 5 of intron 6 (IVS6+5G>A) has such a severe effect on
alternative splicing was previously not understood since this is
outside of the canonical gu_ag consensus sequence (Figure 2C;
Møller et al., 2000).
Using the alternative RNA splicing code, we can now
better explain the alternative splicing phenotypes caused by the
mutations the 5th position of the 5′ splice site of intron 6
of ATP7A. The wild-type sequence guaagu_ag corresponds to
a paired consensus sequence that is over-represented for R-R,
which means that there is little or no alternative splicing in the
wild-type ATP7A gene for this intron (Figure 1A). However, the
5th position mutation (Figure 2C) corresponds to the guaa_ag
paired consensus sequence that is over-represented for the intron
class S-S (Figure 1C). Therefore, the alternative RNA splicing
code helps explain why two adjacent exons, exons 6 and 7,
are skipped as the result of the mutation in the 5th position
(Figure 2C). A similar argument can be made for the milder
ATP7A mutation in OHS, (IVS6+6T>A), which leads to a motif
change to guaag_ag, which is an over-represented motif for the
intron class A3-S, and leads to incomplete exon 6 and/or exon 7
skipping and cryptic splice site usage 50 nucleotides downstream
of the normal 5′ splice site in intron 6, at a second guaag_ag
sequence (Figure 2D). In the OHS allele, exon 6 becomes an A3
exon because the 5′ splice site of exon 5 can join with the normal
3′ splice site or exon 6 or the alternative 3′ splice sites of exon 7
or exon 8 (Figure 2D).
We note that the above analysis for ATP7A intron 6 is an
over simplification of what is required to predict the effect
of an intron mutation because multiple consensus sequences
are often enriched or depleted in several of the 36 types on
introns. For example, the wild type ATP7A intron 6 consensus
sequence, guaagu_ag, corresponds to a consensus sequence that
is enriched for R-R, R-S, and S-APA. Therefore, in order to
predict the outcome of a mutation in a consensus sequence,
one must determine which intron classes are uniquely enriched
when a mutation is present that was not enriched in the wild-
type sequence. The sixth position mutation in OHS has the
intron sequence guaag_ag which is enriched in A3-S and R-R.
This might explain why both A3-S and R-R splicing events are
induced by the OHS mutation (Figure 2D). Similarly, the fifth
FIGURE 2 | ATP7A mutations in Menke’s Disease. (A) Wild type ATP7A intron 6 has the sequence guaagu_ag. The p-value (up) for this sequence in the
Retained—Retained (R-R) class of introns is 2 × 10−14 (2E-14). (B) The MD1 mutation (IVS6+1G>A) in ATP7A causes complete exon 6 and/or exon 7 skipping and
cryptic splice site usage at the 5th position in the intron at the sequence guaag_ag (*). (C) The MD2 mutation (IVS6+5G>A) in ATP7A causes complete exon 6 and/or
exon 7 skipping and has the sequence guaa_ag. The p-value (up) for this sequence in the skipped—skipped (S-S) class of introns is 1 × 10−13 (1E-13). (D) The OHS
mutation (IVS6+6T>A) in ATP7A is a weaker allele that causes incomplete exon 6 and/or exon 7 skipping and cryptic splice site usage at a second guaag_ag motif 50
base pairs downstream of the splice donor site. The p-value (up) for guaag_ag in the Alternative 3′ splice site—skipped class of introns is 3 × 10−4 (3E-4).
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position mutation in MD2 has the sequence guaa_ag, which is
only enriched in the intron type S-S. This might explain why S-
S splicing events are induced by the MD2 mutation (Figure 2C).
The alternative RNA splicing code can also be used to explain+3
to +6 intron mutations in neurofibromatosis type 1 (NF1), one
of themost prevalent inherited disorders in human (Hastings and
Krainer, 2001), beta thalassemia (HBB) (Felber et al., 1982), and
many other human diseases.
In addition to the canonical splicing pathway, which uses
the gu_ag consensus sequence, there are non-canonical (a.k.a.,
minor) splicing pathways that sometimes do not use the gu_ag
consensus (Padgett, 2012). The canonical splicing pathway
generally uses the U1 and U2 small RNAs in their splicing
mechanism, always at gu_ag introns, while the non-canonical
pathway uses U11 and U12 small RNAs, at both gu_ag and
au_ac introns. The U12-like introns also have several conserved
nucleotides that flank the splice donor and splice acceptor
sequences (Padgett, 2012). When we searched for U12-like
consensus sequences in the lists of intron consensus sequences,
we found that human and mouse share the top three U12-
like sequence matches: (1) guauccuuu_ag (Rank 29, Table 1),
(2) auauccuu_ac (Rank 37, Table 1) and (3) guauccuu_ag (Rank
36, Table 1). The U12-like motif guauccuuu_ag is also the
best match with the U12-like splicing pathway in A. thaliana
(Supplementary Table 2). Curiously, both D. melanogaster and
C. elegans have the weakest matches to the U12-like splicing
sequence, gugggu_cag, and guucguuuuu_uuucag, respectively,
even though they are presumably evolutionarily closer to humans
than plants (Supplementary Table 2).
As we showed with mutations that affect the major splicing
machinery, mutations that affect the minor splicing machinery
can also be better interpreted with the paired consensus sequence
motifs that we identified. One example involves a tumor
suppressor gene, LKB1, whose splice acceptor mutation in the
second intron is thought to cause Peutz-Jeghers syndrome (PJS)
(Hastings et al., 2005). This mutation changes the splice junction
sequence from auauccuu_ac to guauccuu_ac, and causes aberrant
splicing, even though the mutation is changing a non-canonical
“au” splice donor to a canonical “gu” splice donor (Figure 3A).
Perusing the alternative RNA splicing code, we noticed that the
wild-type LKB1, auauccuu_ac, is present, but the sequence found
in PJS, guauccuu_ac, is not present on the paired RNA splicing
consensus sequence table in humans (Table 1). Therefore, even
though the consensus sequence table indicates that the splice
donor sequence guauccuu is a goodminor splice donor sequence,
the paired-sequence analyses indicate that the “gu” core splice
donor sequence must be paired with another canonical splice
acceptor sequence, “ag,” even in U12-type introns. In other
words, our analyses suggest that there are at least two distinct
classes of U12-type introns in humans; one with the core
sequence gu_ag and the other with au_ac, and the machinery
that recognizes the two ends of the introns in the U12-type
splicesosomes cannot be swapped. This hypothesis might also
help explain the unusual splicing reactions at the 3′ splice site
FIGURE 3 | The alternative mRNA splicing code predicts the effects of a U12-type intron mutation, IVS2+1A>G, in the LKB1 gene. (A) Schematic of
human LKB1 wild-type gene sequence, has a “auauccuu_ac” U12-like intron consensus sequence. Exon numbers are shown in boxes, sequences belong to exons
are uppercase; lines represent introns, sequences belonging to introns are lowercase. The 5′ and 3′ splice site recognition machinery of the U12 splicesosome
complex are shown schematically. The lariat site is shown as an “A” in a black circle. The red bars represent U11 and the green oval is a simplified version of multiple
interacting factors involved in the splicing events. (B) The mutation in Peutz-Jegher’s syndrome (IVS2+1A>G) changes the U12-like consensus sequence from
auauccuu_ac to guauccuu_ag. However, since no “ag” is detected at the 3′ splice site, cg, au, ug and gg become alternative dinucleotide termini. The red bars
represent U11 and the green oval is a simplified version of multiple interacting factors involved in the splicing events.
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to be multiple cryptic dinucleotide termini (such as cg, au, ug,
and gg) observed from different patients since no “ag” is present
in vicinity of the splice acceptor site (Figure 3B; Hastings et al.,
2005).
Here, we admit that interaction through direct pairing of both
the 5′ and 3′ splice-site recognition complexes is one of the
possible explanations that affect splicing events. In our hypothesis
for developing the alternative splicing code, we emphasized that
the 5′ and 3′ splice sites should be considered as a pair. However,
mostly these sites can be recognized by independent complexes,
5′ splice sites by U1 and 3′ splice sites by U2AF in the first
step of canonical splicing. In addition, in most of the consensus
sequences we identified, the 3′ splice sites are far less variable
than the 5′ splice sites. Other possibilities that could explain the
alteration of splicing events which need to be further investigated
include interaction of splicing enhancers or silencers.
In addition to the long consensus sequences identified in
the U12-type non-canonical introns by rank-order analyses
(Table 1), we found several uncommonly long non-U12-type
consensus sequences (>8 nucleotides) in humans that are also
conserved in mouse, but not C. elegans, D. melanogaster, and
A. thaliana. Splice junctions that are targeted by antisense
oligonucleotides can often block alternative splicing, such as
“morpholino” oligonucleotides that are used to inhibit splicing
(Morcos, 2007). Therefore, one possibility is that the long
consensus sequences might be targets for long-noncoding RNA
or RNA-binding proteins that regulate alternative RNA splicing
in these introns. To test this idea, we used the Mirbase database
(http://www.mirbase.org) to search for complimentary miRNA
sequences for the long human and mouse alternative mRNA
splicing motifs. We found that the long paired alternative
RNA splicing motif gu_uuugagacag (Rank 42, Table 1) is an
excellent match with human hs-miR-6510-3p as well as mouse
mmu-miR-706 (Figure 4A). This bioinformatics result suggests
that this uncommonly long splice site consensus sequence might
be negatively regulated by one of these microRNAs, but this
hypothesis requires genetic validation (Figure 4B).
We also compared alternative splicing consensus sequences
among the 50 species to determine whether they are
evolutionarily conserved and whether they are enriched in
the same classes of introns. The top two consensus sequences
that are shared by the greatest number of species are gugagu_ag
and gu_ag (Figure 5). The motif gugagu_ag is enriched for the
intron class A5-A3 in 10 of the 50 species (Figure 5A), and
the motif gu_ag is enriched in the intron class A5-S in 11 of
the 50 species and depleted in the intron class A5-S in 4 of the
50 species (Figure 5B). Humans and mouse share 80% of all
alternative RNA splicing motifs. When we looked for a possible
reason why D. melanogaster, C. elegans and A. thaliana share
only small portion of significant motifs with human (14, 26, and
29%), we found that, although the canonical sequence gu_ag is
the most highly conserved (98%), the third base after the splicing
donor “gu” varies among taxa. The base adenine was hardly ever
observed in the third position of the intron donor sequence in
D. melanogaster or C. elegans (<1%), while adenine is the most
common nucleotide in the third position in the splice donor, i.e.,
gua_ag, for both human (58.4%) and mouse (58.3%).
FIGURE 4 | Possible regulation of alternative mRNA splicing by miRs.
(A) We used the Mirbase database http://www.mirbase.org to search for
miRNA sequences that might bind to the long human intron motifs,
AGguaagu_uuugagacagagUCUCGCGCU. Human hs-miR-6510-3p as well as
mouse mmu-miR-706n are excellent matches. (B) Donor 5′ and acceptor 3′
consensus motif for the consensus sequence
AGguaagu_uuugagacagagUCUCGCGCU in humans. The intron begins at
position 11 on the left and ends at position 9 on the right.
Next, we used the program High-Throughput GoMiner
(HTGM) (Zeeberg et al., 2005) to analyze and interpret the
functional significance of conserved gene sets that have at least
one intron with identical paired consensus sequences between
humans and A. thaliana. In this analysis, significant Gene
Ontology (GO) categories were determined for genes with a
single particular type of paired consensus sequence in an intron.
Not surprisingly, since they are separated by hundreds of millions
of years of evolution, not many paired alternative splicing
motifs are conserved between humans and plants. However,
the paired motif gugagu_ag is the third most common motif
in A. thaliana (i.e., Rank 3) and the most common motif in
humans (Rank 1). Similarly, gua_ag is the most common motif
in A. thaliana and the 6th most commonmotif in humans. Genes
that have these two sets of motifs in A. thaliana and humans
cluster together in the HTGM analysis with the GO categories
“protein phosphorylation,” “protein tyrosine kinase,” “tRNA
metabolic processes,” “tRNA aminoacetylation,” and “amino acid
activation” (Figure 6A). The identification of GO categories in
protein phosphorylation is interesting because species-specific
alternative exons were analyzed in a recent study, and the two
most enriched keywords are “alternative splicing,” which reflects
the abundant alternative RNA splicing in this set of genes,
and “phosphorylation” (Merkin et al., 2012). Alternative RNA
splicing is used to alter protein phosphorylation, which can alter
protein stability, subcellular localization, and activity (Merkin
et al., 2012). Our results suggest that using alternative RNA
splicing to regulate phosphorylation of proteins might be an
evolutionarily conserved mechanism in plants and humans and
is regulated by these two shared alternative RNA splicing motifs
(Figure 6A).
We also did HTGM analyses of the gene sets with
identical paired alternative RNA splicing sequences in
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FIGURE 5 | Conserved splicing motifs in 50 species. (A) The alternative 5′ splice site—alternative 3′ splice site (A5-A3) class is under represented for the
consensus sequence gugagu_ag in 10 of the 50 species analyzed. (B) Donor and acceptor motif structure for gugagu_ag class. The splice donor (gu) starts at 11 and
the splice acceptor (ag) ends at position 9 (vertical lines). (C) The alternative 5′ splice site—skipped exon (A5-S) class is enriched for the consensus sequence gu_ag
in 11 of the 50 species and depleted in 4 of the 50 species analyzed. The y-axis shows the –log10 p-values for gu_ag introns enrichment (up) or de-enrichment (down)
with the A5-S class. (D) Donor and acceptor motif structure for gu_ag class.
H. sapiens, M. musculis, C. elegans, and Drosophila, but
excluding A. thaliana because it is too divergent from the
other species. Multiple-species cluster analyses of Gene
Ontology categories determined by HTGM indicates that
“cell morphogenesis” and “cell development” and related
GO categories are conserved across the four animal species
for multiple similar consensus sequences (Figure 6B; for a
full HTGM analysis of the four animals see Supplementary
Figure 3). Our HTGM result in the four animal species is
consistent with previous studies demonstrating alternative
splicing is often evolutionarily conserved in a tissue and
developmental stage-specific manner (Chen et al., 2012; Merkin
et al., 2012).
Finally, we wanted to determine whether genes with multiple
introns tend to have the same or different intron consensus
sequences. If, as we hypothesize, the 36 types of introns
in the alternative splicing code table (Table 2) utilize many
different types of splicesosomes, then it is possible that genes
with multiple introns will utilize as few different types of
splicesomes as possible. It might not be practical for different
types of splicesomes to splice each of the different introns in
a gene. Rather, since RNA splicing occurs concurrently with
transcription, it might be more efficient for a particular type of
spicesosome to move on to the next intron once it has completed
the splicing reaction of the upstream intron.
The most significant cluster of intron types with genes with
multiple introns corresponds to U12-like introns (rank 36, 51–52
in mouse) and the second most significant cluster corresponds to
U2-like introns that correspond to the top 12 ranked consensus
sequences (Figure 7). Introns in ranks 13–26 form a third cluster
and introns in ranks 27–50 (excluding rank 36, which is a U12-
type intron) form a fourth cluster, but this is not well segregated
from the third cluster (Figure 7). We interpret this as suggesting,
using the logic in the previous paragraph, that there might be
as many as 3 or 4 different types of splicesosomes in the mouse.
We performed similar cluster analyses in Arabidopsis, C. elegans,
Drosophila, and humans and identified 3 or 4 similar clusters
of intron consensus sequences in genes with multiple introns
(Supplementary Figures 4–7). In humans, rank 1–42 introns all
have remarkably similar distributions in genes with 1–14 introns.
For example, over 50% of all genes have 6–10 introns, and over
50% of all the rank 1–42 introns are in genes with 6–10 introns
(Supplementary Figure 8).
DISCUSSION
The alternative mRNA splicing code in Table 2 provides a
new toolkit for characterizing cis-acting sequences that are
important for generating the enormous diversity of processed
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FIGURE 6 | High Throughput GOMiner Analysis of Alternative Splicing Consensus Sequences. (A) HTGM analysis of human and A. thaliana consensus
sequences shows that phosphorylation and metabolic processes share evolutionarily conserved alternative splicing consensus sequences. The p-values of the GO
classifications are indicated by a heat map where the darkest red has an FDR p-value of 0.001 or less. The consensus sequences are shown on the right and “Rank”
refers to the rank order of introns that have that consensus sequence, where 1 is the most common sequence. The GO categories that are shared are shown on the
bottom and the clustering dendrogram is shown on the top. (B) HTGM analysis of H. sapiens, M. musculus, D. melanogaster, and C. elegans shows that
neurogenesis and developmental processes share evolutionarily conserved alternative splicing consensus sequences. Figure 6B represents only a small portion of
the HTGM analyses of these four animals. See Supplementary Figure 3 for the full HTGM heat map diagram of the four animals analyzed.
mRNAs in animals and plants. Other groups have attempted to
decipher the alternative mRNA splicing code by characterizing
the binding sites for a large number of RNA binding proteins that
are known to affect tissue-specific alternative mRNA splicing,
such as MBNL, PTB, RBFOX, STAR, and TIA families of
splicing factors (Ladd and Cooper, 2002). The research group
of Xiong et al. (2015) have extracted human DNA sequences as
input and used a Bayesian model to predict the percentage of
exons that are spliced in (PSI) based on sequences within the
transcripts. For example, they found among intronic variants
that are known to cause disease alter splicing nine times as
often as the common variant when they are more than 30
nucleotides away from any splice site. We believe that our study
complements the study by Xiong et al. because their program
can be used to calculate PSI-values, whereas, our method will
help to predict the type of alternative splicing that SNPs with
altered PSI-values produce. We did not investigate branchpoints
in our paper, butMercer et al. (2015) analyzed RNA-seq data with
novel bioinformatics methods to identify 60,000 high-confidence
human branchpoints.
Combining our alternative mRNA splicing consensus
sequence information with the RNA-binding protein datasets
should allow the construction of better RNA splicing maps
(Witten and Ule, 2011) that can be used to better understand
the mechanism of tissue-specific alternative mRNA splicing
events. The alternative RNA splicing code can also be used
to better understand how human germline disease mutations
and somatic mutations in cancer affect alternative RNA
splicing and lead to disease etiology. Future biochemical
experiments are needed to test the hypothesis that the
many classes of paired alternative RNA splicing events
in humans with paired consensus sequences have unique
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FIGURE 7 | Cluster analysis of intron consensus sequences in the same gene in mouse. The 53 ranked intron consensus sequences from Mus musculus
were clustered based on whether they were in the same gene as the same or another ranked intron consensus sequence. The diagonal boxes represent unity (i.e., a
gene with a rank 1 intron always has a rank 1 intron, etc.). Notice that ranks 36,51,52, and 53 cluster together (these are all U12 type introns), as well as ranks 1–12
(the most common consensus sequences), 13–26 (the next most common consensus sequences) and ranks 27–50 (except rank 36 which is a U12-type intron in the
first cluster).
macromolecular complexes that regulate RNA maturation.
Future bioinformatics analyses are needed to predict how a
particular splice site mutation in any of the first or last few
nucleotides in an intron precisely affects alternative splicing.
The alternative splicing code should help inform both of these
endeavors.
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MATERIALS AND METHODS
SnpEff Analyses and Identification of
Paired Consensus Sequences
Pre-filtering
For all genes in each analyzed genome, protein-coding transcripts
are curated and filtered out if putative annotation errors or
inconsistencies are found in the reference genome.
Intron Characterization
For all protein coding transcripts, each exon is characterized by
splicing type: retained (R), skipped (S), alternative 3′ splice site
(A3), alternative 5′ splice site (A5), mutually exclusive (ME),
alternative promoter (APr), and alternative poly-A (APA). This
characterization is performed as defined in the text. Each intron
is labeled according to its flanking exons, for instance, an intron
flanked by a retained exon and a skipped exon, is labeled as
retained-skipped (R-S).
Splice Site Sequence Analysis
Unique introns, defined by their genomic coordinates, are
analyzed using their splice site donor and acceptor sequences
using up to 10 bases on each side of the intron. Splice site donor
and acceptor sequences are added to a quaternary tree (a tree
of sequences of A, C, G, T), according to their DNA sequence.
These quaternary trees are paired for splice site donors and
acceptor sequences. Probabilities and entropies are calculated
on each tree branch of these quaternary trees, for all branches
having at least 100 sequences. Pairs of donor acceptor sequences
are selected from the quaternary tree branches in the 95%
probability percentile and the 5% entropy percentile, these are
selected as highly conserved. Fisher exact test is calculated for
each intron category in each conserved splice site sequence
donor-acceptor, over represented (p-value upper tail) or under-
represented (p-value lower tail) categories are reported if their
p-values are <0.001.
Branch Splice Sequence Analysis
Intron sequences near the 3 prime end of the intron, up to
60 bases, are scanned for matching U12 position weighted
matrices (PWMs). The best match in each intron is selected
and the empirical probability distribution is calculated, top
5% scores are selected as significantly matching a U12 motif.
Expected number of matching introns for each intron category
is calculated and intron categories having an unexpected number
of observed/expected matches are selected as significant. The
number of introns matching a top 5% score, as well as
observed/expected ratios are reported.
High throughput GoMiner Analyses
GoMiner (Zeeberg et al., 2003) is a tool for biological
interpretation of ’omic’ data, including data from gene expression
microarrays and state of the art sequencing technologies. It
leverages the Gene Ontology (GO) to identify “biological
processes,” “molecular functions,” and “cellular components”
represented in a list of genes. High-Throughput GoMiner
(HTGM) (Zeeberg et al., 2005), which was used for many of
the analyses reported here, is an enhancement of GoMiner
that efficiently performs the computationally-challenging task
of automated batch processing of an arbitrary number of such
gene lists. A GO category is enriched if the number of changed
genes that HTGM assigned to it is statistically significantly
greater than the number expected by chance. A category is
considered significant if its Fisher’s Exact p-value and its false
discovery rate (FDR) are both less than or equal to a user-
selected threshold (typically 0.10; on rare occasion, the p-
value can exceed the threshold although the FDR is below the
threshold, and we usually want to reject such instances). See
Zeeberg et al. (2003, 2005) for detailed discussions of GoMiner
and HTGM, including calculations of statistical significance.
HTGM runs were performed separately for each of the several
species studies. Parameter values for each run are summarized in
Supplementary Table S4. When results from two or more studies
[i.e., HTGM genes vs. categories clustered image map (CIM)]
were to be combined, In-house R code was used to combine the
individual CIM files into a composite file, and to render the CIM
images.
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